<DOC>
	<DOCNO>NCT01242722</DOCNO>
	<brief_summary>This study collect data , implanted Cardiac Resynchronization Therapy-Defibrillator ( CRT-D ) device , evaluate new feature future heart failure device .</brief_summary>
	<brief_title>Evaluation Left Ventricular Autothreshold , Phase Two</brief_title>
	<detailed_description>ELEVATE 2.0 acute , prospective , multi-center , feasibility study randomize within patient test sequence pulse width , design characterize performance Left Ventricular Auto Threshold ( LVAT ) feature .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients COGNIS CRTD device implant least 24 hour , without right atrial lead Patients active LV bipolar lead Patients active right ventricular ( RV ) defibrillation lead Patients willing capable participate test associate Clinical Investigation Patients age 18 , legal age give inform consent specific state national law Patients COGNIS CRTD less equal one year battery life remain Patients pacemakerdependent Patients tolerate pacing pause 6 second Patients unipolar LV pace/sense lead , unless patient commercially available epicardial lead least two electrode ( one lead ) Patients preexist lead specify investigational plan Patients preexist unipolar pacemaker Patients unable unwilling maintain supine sit position 4050 minute Patients enrol concurrent study , without Boston Scientific write approval Women pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>auto threshold</keyword>
	<keyword>pace</keyword>
	<keyword>CRT-D recipient</keyword>
	<keyword>Left Ventricular ( LV ) evoke response signal</keyword>
</DOC>